Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

54.6K
Overview
54.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccines01:21

Vaccines

55
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
55
Viral Meningitis01:18

Viral Meningitis

146
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
146
Vaccine Production01:23

Vaccine Production

85
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
85
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

54
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
54

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N,N'-bridged heterocyclic bis-iminium salts as potent antimalarial agents against multi-resistant Plasmodium falciparum.

European journal of medicinal chemistry·2025
Same author

Percutaneous sclerotherapy using bleomycine of a macrocystic orbital lymphatic malformation in a seven-year-old child.

Journal francais d'ophtalmologie·2024
Same author

Target fishing reveals PfPYK-1 and PfRab6 as potential targets of an antiplasmodial 4-anilino-2-trichloromethylquinazoline hit compound.

Bioorganic & medicinal chemistry·2024
Same author

Compounding and quality control of two pediatric topiramate pharmaceutical preparations.

Die Pharmazie·2021
Same author

Stockpiled N95 respirator/surgical mask release beyond manufacturer-designated shelf-life: a French experience.

The Journal of hospital infection·2020
Same author

Caplacizumab to treat immune-mediated thrombotic thrombocytopenic purpura.

Drugs of today (Barcelona, Spain : 1998)·2019

Related Experiment Video

Updated: Apr 12, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K

Meningococcal vaccines: Current state and future outlook.

M Leca1, C Bornet2, M Montana3

  • 1Assistance Publique-Hôpitaux de Marseille (AP-HM), Pharmacie Usage Intérieur, Hôpital Nord, 13015 Marseille, France.

Pathologie-Biologie
|May 20, 2015
PubMed
Summary

New vaccines for serogroup B meningococcal infections offer hope for reducing disease incidence. However, cost-effectiveness concerns currently limit routine vaccination recommendations for these novel public health tools.

Keywords:
Bexsero(®)Neisseria meningitidisReverse vaccinologyTrumemba(®)VaccinVaccineVaccinologie inverse

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.6K

Related Experiment Videos

Last Updated: Apr 12, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.6K

Area of Science:

  • Public Health
  • Vaccinology
  • Genomic Medicine

Background:

  • Neisseria meningitidis infections pose a significant global health challenge.
  • Conventional methods have failed to produce a serogroup B meningococcal vaccine.
  • Genome sequencing offers new strategies for vaccine development.

Purpose of the Study:

  • To review the development and implications of new serogroup B meningococcal vaccines.
  • To assess the impact of novel vaccines on public health and epidemiology.
  • To discuss the current recommendations and future considerations for meningococcal vaccination.

Main Methods:

  • Review of clinical studies on vaccine immunogenicity and safety.
  • Analysis of cost-effectiveness data for new vaccines.
  • Epidemiological surveillance of meningococcal infections.

Main Results:

  • Bexsero®, a universal serogroup B meningococcal vaccine, is licensed in major regions.
  • Trumenba®, another serogroup vaccine, is also recently licensed.
  • Clinical trials demonstrate vaccine immunogenicity and safety.

Conclusions:

  • Novel vaccines hold potential to decrease meningococcal infection rates.
  • Cost-effectiveness analyses currently preclude routine vaccination recommendations.
  • Ongoing monitoring of Bexsero® and Trumenba® is crucial for understanding their epidemiological impact.